6,699 Shares in Cardinal Health, Inc. $CAH Purchased by Impact Partnership Wealth LLC

Impact Partnership Wealth LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 6,699 shares of the company’s stock, valued at approximately $1,416,000.

Several other institutional investors have also added to or reduced their stakes in CAH. Norges Bank bought a new stake in shares of Cardinal Health in the fourth quarter valued at approximately $790,344,000. Wellington Management Group LLP boosted its holdings in Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares during the period. Holocene Advisors LP grew its stake in Cardinal Health by 141.4% in the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after buying an additional 1,128,358 shares in the last quarter. Marshall Wace LLP raised its holdings in Cardinal Health by 1,328.1% during the 4th quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after acquiring an additional 884,648 shares during the period. Finally, Barclays PLC raised its holdings in Cardinal Health by 109.3% during the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after acquiring an additional 827,446 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

CAH opened at $237.87 on Wednesday. The firm has a market capitalization of $55.71 billion, a P/E ratio of 36.37, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $240.93. The company has a fifty day moving average price of $207.00 and a 200-day moving average price of $210.93.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is 31.50%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CAH shares. Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. JPMorgan Chase & Co. decreased their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. William Blair began coverage on Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating on the stock. Wells Fargo & Company cut their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Finally, Evercore decreased their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $246.93.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.